コンテンツへスキップ
Merck
  • Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.

Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.

Journal of medicinal chemistry (2011-06-28)
Barbara Taferner, Wolfgang Schuehly, Antje Huefner, Igor Baburin, Katharina Wiesner, Gerhard F Ecker, Steffen Hering
要旨

A series of 31 analogues of the neolignan honokiol (a major constituent of Magnolia officinalis) was synthesized, and their effects on GABA(A) receptors expressed in Xenopus oocytes were investigated. Honokiol enhanced chloride currents (I(GABA)) through GABA(A) receptors of seven different subunit compositions with EC(50) values ranging from 23.4 μM (α(5)β(2)) to 59.6 μM (α(1)β(3)). Honokiol was most efficient on α(3)β(2) (maximal I(GABA) enhancement 2386%) > α(2)β(2) (1130%) > α(1)β(2) (1034%) > α(1)β(1) (260%)). On α(1)β(2)-receptors, N-substituted compounds were most active with 3-acetylamino-4'-O-methylhonokiol (31), enhancing I(GABA) by 2601% (EC(50) (α(1)β(2)) = 3.8 μM). Pharmacophore modeling gave a model with an overall classification accuracy of 91% showing three hydrophobic regions, one acceptor and one donor region. Unlike honokiol, 31 was most efficient on α(2)β(2)- (5204%) > α(3)β(2)- (3671%) > α(1)β(2)-receptors (2601%), suggesting a role of the acetamido group in subunit-dependent receptor modulation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジアゼパム